Fabricating a Partially Fluorinated Hybrid Cation-Exchange Membrane for Long Durable Performance of Vanadium Redox Flow Batteries

The long-term durability of vanadium redox flow batteries (VRFBs) depends on the stability and performance of the membrane separator. We have architected a hybrid membrane by uniform dispersion of MIL-101­(Cr) (Cr-MOF) in a partially fluorinated polymer grafted with sulfonic acid groups (PHP@AMPSCr‑...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS applied materials & interfaces 2023-02, Vol.15 (7), p.9171-9181
Hauptverfasser: Sharma, Prerana, Shahi, Vinod K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The long-term durability of vanadium redox flow batteries (VRFBs) depends on the stability and performance of the membrane separator. We have architected a hybrid membrane by uniform dispersion of MIL-101­(Cr) (Cr-MOF) in a partially fluorinated polymer grafted with sulfonic acid groups (PHP@AMPSCr‑MOF(1.0)). The single cell VRFB performance of the PHP@AMPSCr‑MOF(1.0) membrane was studied in comparison with the Cr-MOF incorporated Nafion membrane (NafionCr‑MOF(1.0)) and showed an excellent result with 97.5% Coulombic efficiency (CE) at 150 mA/cm2 without any significant deterioration in the charge–discharge process for 1500 cycles (over 650 h). Meanwhile, the CE value of the NafionCr‑MOF membrane (94.5%) deteriorated after 800 cycles (about 360 h) under similar conditions. The high VRFB performance of the PHP@AMPSCr‑MOF(1.0) membrane has been attributed to the synergized properties and good interactions between Cr-MOF and partially fluorinated polymer matrix responsible for the creation of hydrophilic proton-conducting channels to achieve high selectivity. Furthermore, the cost-effective polymer and thus membranes may open new windows for practical applications in other energy devices such as fuel cells, electrolysis, and water treatment.
ISSN:1944-8244
1944-8252
DOI:10.1021/acsami.2c16720